SCHEMBL164427

SCHEMBL164427

C[CH]S(C)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11206286 0.74
SCHEMBL5393533 0.70
SCHEMBL1396576 0.70
SCHEMBL342501 0.70
SCHEMBL1266814 0.70
SCHEMBL19196417 0.70 KDM4E (0.46)
SCHEMBL29683 0.67
SCHEMBL21772 0.67
SCHEMBL107272 0.67
SCHEMBL11721633 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2517 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115724857-B Aromatic heterocyclic compound, pharmaceutical composition containing aromatic heterocyclic compound and application of aromatic heterocyclic compound 杭州禹泓医药科技有限公司 2024-06-21 CN claimed
EP-4385993-A1 AROMATIC HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF Hang Zhou Yuhong Pharmatech Co., Ltd. (CN) 2024-06-19 EP claimed
EP-4334315-A1 ALKYLAMIDE SUBSTITUTED, ANNULATED IMIDAZOLES AND USE THEREOF AS INSECTICIDES Bayer Aktiengesellschaft (DE) 2024-03-13 EP claimed
CN-111712507-B Method for improving oral bioavailability of drugs 药物有限公司 2024-02-06 CN claimed
EP-4298097-A1 BENZOTHIAZOLYL BICYCLO[1.1.1]PENTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2024-01-03 EP claimed
US-20230391764-A1 BENZOTHIAZOLYL BICYCLO[1.1.1]PENTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HOFFMANN-LA ROCHE INC. (US) 2023-12-07 US claimed
CN-113286792-B N-chromen-4-one containing derivatives for the treatment and prevention of hepatitis b virus infection 豪夫迈·罗氏有限公司 2023-12-05 CN claimed
WO-2023203187-A1 PRODRUG INTENDED FOR THE TREATMENT OF BACTERIAL INFECTIONS RESISTANT TO ANTIBIOTICS OF THE BETA-LACTAM FAMILY OSTA THERAPEUTICS (FR) 2023-10-26 WO claimed
CN-116897149-A Preparation method of linker drug conjugate and intermediate thereof 上海复旦张江生物医药股份有限公司 2023-10-17 CN claimed
EP-3388433-B1 PHTHALAZINE DERIVATIVES, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF SHANGHAI SIMR BIOTECH CO LTD (CN) 2023-08-30 EP claimed
EP-0235628-A2 1-Arylpyrazoles BAYER AG (DE) 1987-09-09 EP claimed
EP-0231510-A2 1-Aryl pyrazoles BAYER AG (DE) 1987-08-12 EP claimed
US-4600532-A Process and composition for amino-terminal, α-aspartyl and α-glutamyl dipeptides and dipeptide esters THE SALK INSTITUTE BIOTECHNOLOGY/INDUSTRIAL ASSOCIATES, INC. (US) 1986-07-15 US claimed
US-4552694-A ANTISEPTICS, INSECTICIDES DAIKIN INDUSTRIES LTD. (JP) 1985-11-12 US claimed
EP-0134041-A1 N-Chlorocarbonyloxy-5-norbornene-2,3-dicarboximide, process for its preparation and its use Akademie der Wissenschaften der DDR (DE) 1985-03-13 EP claimed
EP-0133322-A1 Fluorinated benzodiazepins DAIKIN INDUSTRIES, LIMITED (JP) 1985-02-20 EP claimed
EP-0131993-A2 Phosphorylating agent; a process for the preparation thereof; a process for phosphorylating an organic hydroxyl or amine compound Stichting Katholieke Universiteit (NL) 1985-01-23 EP claimed
EP-0096296-A2 1-Sulfo-2-oxoazetidine derivatives F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1983-12-21 EP claimed
US-4248886-A Combating fungi with N-oxalyl-N-phenyl-aminoacids and esters thereof BAYER AKTIENGESELLSCHAFT (DE) 1981-02-03 US claimed
US-4145540-A ANTIBIOTICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1979-03-20 US claimed